In the News
WBUR Covers Convergence of AI and Precision Medicine
June 8, 2018 – WBUR, the largest of the three Boston NPR-affiliates, produced a series on the biotech boom in Boston this week, coinciding with the 2018 BIO conference that took place at the Boston Convention Center from June 4-7. Today, reporter Karen Weintraub dove...
read moreColin Hill joins Bloomberg Baystate Business Radio Hour
Colin Hill, Chairman, CEO and Co-founder of GNS Healthcare, joined Bloomberg Boston Bureau Chief Tom Moroney and Radio News Anchors Peter Barnes and Pat Carroll on May 9 for their weekly C-Suite segment. Colin talks about the GNS Healthcare's approach to precision...
read moreIya Khalil featured in Forbes article on women making AI more accessible
May 7, 2018 –Artificial intelligence is impacting every industry so it is no wonder that this year's Milken Global Institute focused how new technologies are changing industries, including health care. Forbes recently profiled the event, focusing on the number of...
read moreIya Khalil Joins Massachusetts Health Information and Analysis Oversight Council
BOSTON, Mass. – April 4, 2018 – GNS announced today that Co-Founder and Chief Commerical Officer Iya Khalil has been appointed to the Massachusetts Health Information and Analysis Oversight Council. The Council, created by Governor Charlie Baker in 2015, is charged...
read moreColin Hill featured in STAT News Article on Patient Data
March 29, 2018 – In early March, the Centers for Medicare and Medicaid Services (CMS) announced two initiatives, MyHealthEData and Blue Button 2.0, which aims to improve the control that patients have over their health data. In a recent STAT News article, GNS...
read moreGNS Board Member Dr. Adrian Weller appointed as Programme Director for Artificial Intelligence at The Alan Turing Institute
Today, The Alan Turing Institute announced the appointment of Dr. Adrian Weller as Programme Director for Artificial Intelligence. The Institute, named in honor of Alan Turing and based in London, aims to make great leaps in data science research in order to change...
read moreRoche Precision Medicine Article Features Iya Khalil
Dr. Iya Khalil, GNS chief commercial officer and co-founder, gave her perspectives on the application of machine learning to clinical trials in "Partnering in the Digital Era", an article published by Roche this week. The precision medicine piece focuses on how...
read moreNeo.Life features Iya Khalil in 2018 Biotech Breakthroughs and Big Ideas
In this January article, Neo.Life profiles the biggest biotech breakthroughs and big ideas for 2018, including thoughts from Iya Khalil, GNS co-founder and chief commercial officer. Iya speaks to the proliferation of emerging -omic data and how advances in artificial...
read morePPD Names Colin Hill, CEO of GNS Healthcare, to its Board of Directors
Pharmaceutical Product Development, LLC (PPD) today announced that Colin Hill has been named to the company’s board of directors. Hill is the chairman, chief executive officer and co-founder of GNS Healthcare, a leading precision medicine company. “Colin Hill is a...
read moreGenentech oncology collaboration with GNS featured in TechEmergence
October 11, 2017 by Jon Walker Genentech, a member of the Roche Group, this summer announced their own collaboration with Cambridge, MA-based GNS Healthcare. GNS Healthcare’s mission statement is to use the latest innovations in machine learning to turn biomedical...
read more